EXTON, PA — West Pharmaceutical Services, Inc. (NYSE: WST) announced plans to participate in several investor conferences ...

Creating change and healing communities through music is goal of one Memphis native who recently received a full scholarship ...

Drugmakers are investing more in U.S. manufacturing as President Donald Trump threatens tariffs, but facilities can take ...

Climate change-driven weather disasters like hurricanes, wildfires and floods pose an immediate threat to the U.S. drug ...

Following FDA IND clearance for neuropathic pain, the Company is preparing to initiate its U.S. Phase 2a trial in Q4 2025 ...

Setmelanotide is a melanocortin-4 receptor (MC4R) agonist, previously approved as IMCIVREE ® by the FDA, the EMA, and UK’s Medicines & Healthcare Products Regulatory Agency (MHRA) for obesity due to ...

As China rises and other global cities aggressively court biotech talent, Massachusetts faces a "contracting moment" that has ...

A webcast of the H.C. Wainwright presentation will be available on September 9 at 12:00 PM EDT. The webcast will be available to watch live and a replay will be available for approximately 90-days ...